We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Colonoscopy and OGD Infection Risk Higher Than Expected

By HospiMedica International staff writers
Posted on 20 Jun 2018
Colonoscopies and osophagogastroduodenoscopies (OGDs) performed at outpatient specialty centers result in far more infections than previously believed, according to a new study.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) conducted a study to estimate the rates of infections following colonoscopy and OGD procedures performed during 2014 in ambulatory surgery centers (ASCs) in the states of California, Florida, Georgia, Nebraska, New York, and Vermont. More...
The researchers identified infection-related emergency department (ED) visits and in-patient admissions within 7 and 30 days of the screening procedure, noted infection sites and organisms, and analyzed predictors of infections. Screening mammography, prostate cancer screening, bronchoscopy, and cystoscopy procedures were comparators.

The results revealed post-endoscopic infection rates of 1.1 per 1,000 for screening colonoscopy, 1.6 for non-screening colonoscopy, and 3 for OGD procedures; all higher than screening mammography (0.6), but lower than bronchoscopy (15.6) and cystoscopy (4.4). The rates of 7-day post-endoscopic infections varied widely by ASC, ranging from 0-115 per 1,000 procedures for screening colonoscopy, 0-132 for non-screening colonoscopy and 0-62 for OGD. Predictors included recent history of hospitalization or endoscopic procedure; low procedure volume or non-freestanding ASC; younger or older age; black or Native American race, and male sex. The study was published in the May 2018 issue of Gut.

“Patients who had been hospitalized before undergoing one of the procedures were at even greater risk of infection,” said senior author Susan Hutfless, MD, of the division of gastroenterology and hepatology. “Since many ASCs lack an electronic medical record system connected to hospital EDs, those ASCs are unlikely to learn of their patients' infections. If they don't know their patients are developing these serious infections, they're not motivated to improve their infection control.”

More than 15 million colonoscopies and seven million EGDs are performed annually in the United States alone; both procedures are performed with reusable endoscopes. Inadequate reprocessing between patients can result in retention of blood, tissue, and other biological debris, which can allow microbes to survive the disinfection or sterilization process. Inadequate reprocessing can also result in other adverse patient outcomes, such as tissue irritation from residual chemical disinfectants.

Related Links:
Johns Hopkins University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.